Meyka Pro banner
Take-Two Interactive Software, Inc.

Stay Updated with the Latest Take-Two Interactive Software, Inc. TTWO News in Real Time

Find TTWO news now at Meyka AI. Stay informed with the latest Take-Two Interactive Software, Inc. stocks updates, including price news, market analysis, and expert insights.

TTWONASDAQ
TechnologyElectronic Gaming & Multimedia
$241.61
$5.34(2.16%)
U.S. Market opens in 2h 44m
Ausgold Jumps on $776M Takeover as Oil Tops $90 and ASX 200 Stays Flat
📅 in about 4 hours

Ausgold Jumps on $776M Takeover as Oil Tops $90 and ASX 200 Stays Flat

Ausgold shares surged on August 18, 2026, after OceanaGold agreed to acquire the company in a A$776 million deal. The offer values Ausgold at A$1.36 per share, a 28% premium to its last close. Brent crude climbed 2.3% to US$90.52 a barrel the same day. The ASX 200 finished flat at 9,070 points, down just…

Read more 12
Coles and Woolworths Test Facial Recognition as Privacy Concerns Mount, August 18
📅 in 36 minutes

Coles and Woolworths Test Facial Recognition as Privacy Concerns Mount, August 18

Coles and Woolworths have tested facial recognition technology in their Australian stores to reduce retail crime. Privacy advocates warn of surveillance risks as the Privacy Commission cautions retailers against rollout without proper safeguards.

Read more 12
Adani Shares Surge 34% in 2026 as Flagship Stock Eyes Nifty 50’s Top Gainer Crown
📅 in 21 minutes

Adani Shares Surge 34% in 2026 as Flagship Stock Eyes Nifty 50’s Top Gainer Crown

Adani shares have jumped 34% so far in 2026, making Adani Enterprises the top performer on the Nifty 50 Index. The flagship stock last held that spot at the end of 2022, right before the Hindenburg Research report hit in January 2023. This rally marks a full turnaround for Asia’s richest man, Gautam Adani, and…

Read more 12
Milky Mist Share Price: Shares List at ₹165 on NSE and BSE After 18% Premium Debut
📅 8 minutes ago

Milky Mist Share Price: Shares List at ₹165 on NSE and BSE After 18% Premium Debut

Milky Mist Dairy Food shares debuted at ₹165 on both NSE and BSE on August 18, 2026. That marked a gain of ₹25, or 17.86%, over the ₹140 issue price. The stock later hit the 10% upper circuit at ₹181.45 on the BSE. Milky Mist’s listing beat grey market expectations, which had pointed to a…

Read more 12
Nike Stock Drops 4% to 12-Year Low Below $40 as Downgrades and Weak Sales Raise Turnaround Risks
📅 15 minutes ago

Nike Stock Drops 4% to 12-Year Low Below $40 as Downgrades and Weak Sales Raise Turnaround Risks

Nike stock faced fresh selling pressure on August 17, 2026, falling about 4% and moving below the $40 mark. The shares touched around $38.85, their lowest level since 2014. Weak sales, softer footwear demand, and new analyst downgrades have added to concerns about Nike’s turnaround. Investors are now watching to see whether the sportswear giant…

Read more 12
Former DBS Chief Gupta Urges Singapore to Take Bigger Risks in Finance
📅 3 hours ago

Former DBS Chief Gupta Urges Singapore to Take Bigger Risks in Finance

Former DBS CEO Piyush Gupta warns Singapore’s financial sector must resist risk aversion and embrace innovation to stay competitive. He praised recent bold moves like EQDP and suggested exploring SGD-backed stablecoins.

Read more 12
Actor Shinoyama Akianobu Wins ¥2.06M in Entertainment Industry Contract Case
📅 14 hours ago

Actor Shinoyama Akianobu Wins ¥2.06M in Entertainment Industry Contract Case

Actor Shinoyama Akianobu wins ¥2.06M lawsuit against talent agency over unpaid consumption tax on performance fees. Tokyo court rules agency violated contract terms.

Read more 12
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
📅 17 hours ago

AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit

AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review.  This marks AstraZeneca’s second major trial halt…

Read more 12
Alibaba (NYSE: BABA) to Sell Lingxi Games to Trustar Capital in Deal Worth Over $2 Billion
📅 20 hours ago

Alibaba (NYSE: BABA) to Sell Lingxi Games to Trustar Capital in Deal Worth Over $2 Billion

Alibaba Group Holding Limited agreed on August 17, 2026, to sell its gaming arm, Lingxi Games, to Trustar Capital. The deal values the gaming unit at above $2 billion. Alibaba shares rose 1.25% to trade near $84.50 following the announcement. This transaction aligns with the tech giant’s strategy to shed non-core assets and focus on…

Read more 12

TTWO News FAQ